Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukodystrophy, Metachromatic | 20 | 2022 | 44 | 6.110 |
Why?
|
Lysosomal Storage Diseases | 9 | 2022 | 81 | 3.190 |
Why?
|
Hematopoietic Stem Cell Transplantation | 42 | 2024 | 5717 | 3.060 |
Why?
|
Hematopoietic Stem Cells | 23 | 2024 | 3409 | 3.050 |
Why?
|
Microglia | 12 | 2024 | 1376 | 2.440 |
Why?
|
Lentivirus | 17 | 2024 | 518 | 2.280 |
Why?
|
Cerebroside-Sulfatase | 9 | 2022 | 15 | 2.250 |
Why?
|
Central Nervous System | 6 | 2024 | 1346 | 1.700 |
Why?
|
Mucopolysaccharidosis I | 6 | 2022 | 53 | 1.480 |
Why?
|
Genetic Vectors | 19 | 2022 | 3402 | 1.280 |
Why?
|
Adrenoleukodystrophy | 5 | 2020 | 144 | 1.240 |
Why?
|
Iduronidase | 4 | 2020 | 31 | 1.130 |
Why?
|
Metallothionein | 2 | 2018 | 62 | 1.040 |
Why?
|
Hematology | 5 | 2024 | 243 | 0.970 |
Why?
|
Galactosylceramidase | 5 | 2015 | 23 | 0.960 |
Why?
|
Wiskott-Aldrich Syndrome | 3 | 2022 | 131 | 0.950 |
Why?
|
Italy | 12 | 2024 | 856 | 0.930 |
Why?
|
Iduronate Sulfatase | 1 | 2024 | 10 | 0.920 |
Why?
|
Leukodystrophy, Globoid Cell | 6 | 2019 | 38 | 0.920 |
Why?
|
Mucopolysaccharidosis II | 1 | 2024 | 26 | 0.900 |
Why?
|
Haploinsufficiency | 1 | 2024 | 334 | 0.820 |
Why?
|
Transplantation Conditioning | 7 | 2024 | 1601 | 0.820 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 2 | 2019 | 134 | 0.770 |
Why?
|
beta-Thalassemia | 5 | 2019 | 234 | 0.750 |
Why?
|
Lysosomal Storage Diseases, Nervous System | 2 | 2012 | 8 | 0.750 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2020 | 44 | 0.700 |
Why?
|
Gangliosidoses | 1 | 2019 | 5 | 0.680 |
Why?
|
Anemia, Sickle Cell | 5 | 2023 | 1065 | 0.680 |
Why?
|
Mucopolysaccharidoses | 1 | 2019 | 27 | 0.670 |
Why?
|
Leukemia | 3 | 2023 | 1519 | 0.610 |
Why?
|
Homocystinuria | 1 | 2018 | 65 | 0.600 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2024 | 230 | 0.590 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.580 |
Why?
|
Blood Component Removal | 1 | 2018 | 132 | 0.570 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2018 | 225 | 0.570 |
Why?
|
Heterocyclic Compounds | 1 | 2018 | 245 | 0.570 |
Why?
|
Stem Cell Niche | 2 | 2011 | 347 | 0.570 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2024 | 1027 | 0.560 |
Why?
|
Mice, Transgenic | 5 | 2024 | 9561 | 0.550 |
Why?
|
Disease Models, Animal | 13 | 2024 | 18349 | 0.550 |
Why?
|
Transduction, Genetic | 7 | 2019 | 899 | 0.550 |
Why?
|
Neurodegenerative Diseases | 2 | 2024 | 1095 | 0.540 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2023 | 168 | 0.540 |
Why?
|
Hydrolases | 1 | 2017 | 146 | 0.530 |
Why?
|
Brain Damage, Chronic | 1 | 2017 | 265 | 0.520 |
Why?
|
Saposins | 1 | 2015 | 22 | 0.510 |
Why?
|
Gene Transfer Techniques | 6 | 2019 | 1207 | 0.500 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2015 | 24 | 0.490 |
Why?
|
Precursor Cells, T-Lymphoid | 1 | 2015 | 19 | 0.490 |
Why?
|
Cerebral Ventricles | 1 | 2017 | 550 | 0.490 |
Why?
|
Neuroblastoma | 4 | 2024 | 1266 | 0.480 |
Why?
|
Metabolic Diseases | 2 | 2020 | 684 | 0.470 |
Why?
|
Child | 50 | 2024 | 80917 | 0.440 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 384 | 0.440 |
Why?
|
Animals | 42 | 2024 | 169246 | 0.410 |
Why?
|
Mice | 32 | 2024 | 82029 | 0.410 |
Why?
|
Polymers | 1 | 2019 | 1630 | 0.390 |
Why?
|
Graft vs Host Disease | 5 | 2024 | 3049 | 0.380 |
Why?
|
Humans | 110 | 2024 | 768166 | 0.370 |
Why?
|
Regenerative Medicine | 1 | 2015 | 313 | 0.370 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 958 | 0.370 |
Why?
|
MicroRNAs | 6 | 2024 | 3803 | 0.360 |
Why?
|
Molecular Dynamics Simulation | 1 | 2014 | 427 | 0.360 |
Why?
|
Burkitt Lymphoma | 2 | 2024 | 338 | 0.350 |
Why?
|
Nanoparticles | 2 | 2019 | 1985 | 0.350 |
Why?
|
Communicable Diseases | 3 | 2024 | 874 | 0.340 |
Why?
|
Cyclophosphamide | 3 | 2024 | 2227 | 0.330 |
Why?
|
Mice, Inbred C57BL | 13 | 2024 | 22379 | 0.330 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7477 | 0.330 |
Why?
|
Nervous System Diseases | 2 | 2017 | 1662 | 0.310 |
Why?
|
Granulomatous Disease, Chronic | 2 | 2021 | 175 | 0.300 |
Why?
|
Bone Marrow | 4 | 2023 | 2935 | 0.300 |
Why?
|
Brain | 11 | 2023 | 27360 | 0.290 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 2 | 2022 | 163 | 0.290 |
Why?
|
Isoquinolines | 1 | 2009 | 354 | 0.280 |
Why?
|
Immunophenotyping | 5 | 2024 | 1864 | 0.280 |
Why?
|
Transgenes | 3 | 2019 | 1016 | 0.280 |
Why?
|
Child, Preschool | 23 | 2024 | 42669 | 0.280 |
Why?
|
Flow Cytometry | 6 | 2023 | 5902 | 0.280 |
Why?
|
Leukocytes, Mononuclear | 1 | 2014 | 1854 | 0.270 |
Why?
|
Cell Differentiation | 9 | 2024 | 11669 | 0.270 |
Why?
|
Natural Killer T-Cells | 1 | 2009 | 318 | 0.260 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2744 | 0.260 |
Why?
|
Regeneration | 1 | 2015 | 1524 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.260 |
Why?
|
Antigens, CD34 | 4 | 2019 | 657 | 0.250 |
Why?
|
Killer Cells, Natural | 1 | 2015 | 2211 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3238 | 0.250 |
Why?
|
Mice, Knockout | 13 | 2019 | 14488 | 0.250 |
Why?
|
Mental Health | 1 | 2020 | 3275 | 0.250 |
Why?
|
Acetates | 2 | 2024 | 317 | 0.240 |
Why?
|
Immunotherapy, Adoptive | 1 | 2015 | 1512 | 0.240 |
Why?
|
Thrombocytopenia | 2 | 2023 | 1179 | 0.240 |
Why?
|
Anxiety | 1 | 2020 | 4672 | 0.240 |
Why?
|
Receptors, GABA-A | 1 | 2009 | 625 | 0.240 |
Why?
|
Central Nervous System Diseases | 1 | 2009 | 520 | 0.230 |
Why?
|
Virus Integration | 4 | 2019 | 307 | 0.230 |
Why?
|
Influenza B virus | 1 | 2024 | 53 | 0.230 |
Why?
|
Infant | 15 | 2024 | 36535 | 0.230 |
Why?
|
Enzyme Replacement Therapy | 3 | 2022 | 80 | 0.220 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2024 | 3626 | 0.220 |
Why?
|
Mutation | 7 | 2024 | 30238 | 0.220 |
Why?
|
Pandemics | 2 | 2020 | 8748 | 0.220 |
Why?
|
Adolescent | 23 | 2024 | 89169 | 0.210 |
Why?
|
Leukemia, Myelomonocytic, Juvenile | 1 | 2023 | 24 | 0.210 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1887 | 0.210 |
Why?
|
gamma-Globins | 2 | 2020 | 105 | 0.210 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8759 | 0.210 |
Why?
|
Cyclosporine | 2 | 2019 | 777 | 0.200 |
Why?
|
Pancytopenia | 1 | 2023 | 102 | 0.200 |
Why?
|
Interleukin-7 | 1 | 2022 | 146 | 0.190 |
Why?
|
Histiocytosis | 1 | 2021 | 40 | 0.190 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2024 | 305 | 0.190 |
Why?
|
B-Lymphocyte Subsets | 1 | 2022 | 241 | 0.190 |
Why?
|
Fanconi Anemia | 1 | 2024 | 327 | 0.190 |
Why?
|
Vestibular Diseases | 1 | 2024 | 232 | 0.190 |
Why?
|
Neoplasm, Residual | 2 | 2024 | 1015 | 0.190 |
Why?
|
Antigens, CD19 | 1 | 2024 | 446 | 0.190 |
Why?
|
Adenoviridae Infections | 1 | 2021 | 96 | 0.180 |
Why?
|
Agammaglobulinemia | 1 | 2022 | 174 | 0.180 |
Why?
|
Paramyxoviridae Infections | 1 | 2021 | 57 | 0.180 |
Why?
|
Sulfoglycosphingolipids | 2 | 2013 | 31 | 0.180 |
Why?
|
Fetal Hemoglobin | 2 | 2020 | 346 | 0.180 |
Why?
|
Histiocytic Sarcoma | 1 | 2021 | 40 | 0.180 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1907 | 0.180 |
Why?
|
Familial Mediterranean Fever | 1 | 2021 | 65 | 0.180 |
Why?
|
Green Fluorescent Proteins | 3 | 2017 | 2065 | 0.180 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2024 | 812 | 0.180 |
Why?
|
Macrophage Activation Syndrome | 1 | 2021 | 124 | 0.180 |
Why?
|
Nephrocalcinosis | 1 | 2020 | 51 | 0.180 |
Why?
|
Stomatitis | 1 | 2023 | 271 | 0.170 |
Why?
|
In Situ Nick-End Labeling | 2 | 2012 | 611 | 0.170 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1418 | 0.170 |
Why?
|
Comparative Genomic Hybridization | 1 | 2021 | 474 | 0.170 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2020 | 77 | 0.170 |
Why?
|
Hematologic Diseases | 1 | 2024 | 498 | 0.170 |
Why?
|
Quinazolines | 2 | 2024 | 1373 | 0.170 |
Why?
|
Reed-Sternberg Cells | 1 | 2020 | 78 | 0.170 |
Why?
|
Depression | 1 | 2020 | 8230 | 0.170 |
Why?
|
Female | 37 | 2024 | 397192 | 0.170 |
Why?
|
Genetic Engineering | 2 | 2017 | 936 | 0.170 |
Why?
|
Male | 36 | 2024 | 364719 | 0.160 |
Why?
|
Sulfatases | 2 | 2010 | 44 | 0.160 |
Why?
|
Neonatal Screening | 2 | 2020 | 620 | 0.160 |
Why?
|
Busulfan | 2 | 2009 | 259 | 0.160 |
Why?
|
Mucormycosis | 1 | 2019 | 102 | 0.160 |
Why?
|
Quality of Life | 1 | 2020 | 13490 | 0.150 |
Why?
|
Neoplasms | 3 | 2024 | 22371 | 0.150 |
Why?
|
Face | 1 | 2024 | 1029 | 0.150 |
Why?
|
Hospitals, Pediatric | 2 | 2024 | 1876 | 0.150 |
Why?
|
Hydrazones | 1 | 2018 | 105 | 0.150 |
Why?
|
Glycosaminoglycans | 1 | 2020 | 611 | 0.150 |
Why?
|
Hypercalcemia | 1 | 2020 | 424 | 0.140 |
Why?
|
Benzylamines | 1 | 2018 | 251 | 0.140 |
Why?
|
Microbial Sensitivity Tests | 1 | 2024 | 1967 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2024 | 837 | 0.140 |
Why?
|
Gene Expression | 4 | 2017 | 7598 | 0.140 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2018 | 263 | 0.140 |
Why?
|
Cell Separation | 3 | 2019 | 1728 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 661 | 0.140 |
Why?
|
Transplantation, Homologous | 3 | 2024 | 4833 | 0.140 |
Why?
|
Influenza Vaccines | 1 | 2024 | 781 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 462 | 0.140 |
Why?
|
Abnormalities, Multiple | 1 | 2024 | 1424 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 617 | 0.130 |
Why?
|
Polyesters | 1 | 2018 | 377 | 0.130 |
Why?
|
Exosomes | 1 | 2021 | 422 | 0.130 |
Why?
|
Cerebrospinal Fluid | 1 | 2019 | 540 | 0.130 |
Why?
|
Hematopoiesis | 2 | 2019 | 2059 | 0.130 |
Why?
|
Prodrugs | 1 | 2018 | 274 | 0.130 |
Why?
|
Laser Therapy | 1 | 2023 | 1107 | 0.130 |
Why?
|
Coculture Techniques | 3 | 2017 | 1340 | 0.130 |
Why?
|
Membrane Glycoproteins | 2 | 2024 | 3711 | 0.130 |
Why?
|
Bayes Theorem | 1 | 2024 | 2359 | 0.130 |
Why?
|
Growth Disorders | 1 | 2020 | 635 | 0.130 |
Why?
|
Vitamin B 12 | 1 | 2018 | 529 | 0.120 |
Why?
|
Genetic Loci | 1 | 2024 | 2629 | 0.120 |
Why?
|
Alleles | 3 | 2015 | 6894 | 0.120 |
Why?
|
Lymphoma | 1 | 2023 | 1898 | 0.120 |
Why?
|
Dependovirus | 1 | 2019 | 720 | 0.110 |
Why?
|
Spinal Cord | 2 | 2019 | 1811 | 0.110 |
Why?
|
Immunoglobulin G | 3 | 2022 | 4568 | 0.110 |
Why?
|
Biotechnology | 1 | 2016 | 283 | 0.110 |
Why?
|
Rare Diseases | 1 | 2019 | 631 | 0.110 |
Why?
|
China | 1 | 2020 | 2395 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2954 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1037 | 0.110 |
Why?
|
Age of Onset | 2 | 2022 | 3347 | 0.110 |
Why?
|
Retrospective Studies | 13 | 2024 | 81762 | 0.110 |
Why?
|
Myelodysplastic Syndromes | 1 | 2023 | 1399 | 0.110 |
Why?
|
Genotype | 3 | 2015 | 13045 | 0.110 |
Why?
|
Lymphoma, B-Cell | 1 | 2020 | 945 | 0.110 |
Why?
|
Influenza, Human | 1 | 2024 | 1541 | 0.100 |
Why?
|
Databases, Genetic | 2 | 2021 | 1758 | 0.100 |
Why?
|
Cell Tracking | 1 | 2014 | 140 | 0.100 |
Why?
|
Thiazolidinediones | 1 | 2016 | 461 | 0.100 |
Why?
|
Bacteria | 1 | 2024 | 2216 | 0.100 |
Why?
|
Infant, Newborn | 9 | 2024 | 26422 | 0.100 |
Why?
|
Gliosis | 2 | 2015 | 246 | 0.100 |
Why?
|
Myeloid Cells | 1 | 2017 | 839 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2020 | 2982 | 0.100 |
Why?
|
Visual Cortex | 1 | 2020 | 1094 | 0.100 |
Why?
|
Neoplasm Metastasis | 1 | 2023 | 4912 | 0.100 |
Why?
|
Fluorescent Dyes | 1 | 2020 | 1930 | 0.100 |
Why?
|
Magnetite Nanoparticles | 1 | 2014 | 312 | 0.100 |
Why?
|
Hodgkin Disease | 1 | 2020 | 1384 | 0.100 |
Why?
|
Dextrans | 1 | 2014 | 574 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2832 | 0.100 |
Why?
|
Phenotype | 4 | 2021 | 16726 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2020 | 1885 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 7 | 2021 | 36743 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2045 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1169 | 0.100 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 259 | 0.100 |
Why?
|
Critical Care | 1 | 2024 | 2715 | 0.090 |
Why?
|
Bone Marrow Cells | 3 | 2019 | 2414 | 0.090 |
Why?
|
Lysosomes | 1 | 2017 | 938 | 0.090 |
Why?
|
Doxorubicin | 1 | 2018 | 2234 | 0.090 |
Why?
|
Cells, Cultured | 8 | 2019 | 19015 | 0.090 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2011 | 89 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2022 | 2663 | 0.090 |
Why?
|
Enzymes | 1 | 2012 | 254 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2018 | 1281 | 0.090 |
Why?
|
Amyloid beta-Peptides | 1 | 2024 | 3914 | 0.090 |
Why?
|
Cell Line | 4 | 2019 | 15597 | 0.090 |
Why?
|
Macrophages | 3 | 2023 | 5799 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.090 |
Why?
|
Multiple Sulfatase Deficiency Disease | 1 | 2009 | 2 | 0.090 |
Why?
|
Sandhoff Disease | 1 | 2009 | 14 | 0.090 |
Why?
|
U937 Cells | 1 | 2010 | 260 | 0.090 |
Why?
|
Image Enhancement | 1 | 2020 | 2880 | 0.080 |
Why?
|
Myelin Sheath | 2 | 2015 | 652 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2018 | 10760 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 8054 | 0.080 |
Why?
|
Antiviral Agents | 4 | 2024 | 3073 | 0.080 |
Why?
|
Hemoglobinopathies | 1 | 2010 | 101 | 0.080 |
Why?
|
Enterococcus faecium | 1 | 2010 | 101 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2009 | 69 | 0.080 |
Why?
|
Spleen | 2 | 2019 | 2295 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2024 | 65371 | 0.080 |
Why?
|
Pilot Projects | 2 | 2020 | 8741 | 0.080 |
Why?
|
Sphingolipids | 1 | 2010 | 178 | 0.080 |
Why?
|
Schwann Cells | 1 | 2009 | 196 | 0.080 |
Why?
|
HeLa Cells | 3 | 2009 | 3074 | 0.080 |
Why?
|
Polydeoxyribonucleotides | 1 | 2009 | 136 | 0.080 |
Why?
|
Transplantation Chimera | 1 | 2011 | 594 | 0.080 |
Why?
|
Cytomegalovirus | 2 | 2024 | 753 | 0.070 |
Why?
|
Bone Marrow Transplantation | 2 | 2015 | 2709 | 0.070 |
Why?
|
Carbon Radioisotopes | 1 | 2009 | 567 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3603 | 0.070 |
Why?
|
beta-Galactosidase | 1 | 2009 | 574 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2232 | 0.070 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2009 | 220 | 0.070 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2010 | 342 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5330 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3591 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1754 | 0.070 |
Why?
|
Mice, Inbred Strains | 1 | 2009 | 1765 | 0.070 |
Why?
|
Heterozygote | 1 | 2013 | 2798 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2945 | 0.070 |
Why?
|
Cell Movement | 2 | 2012 | 5210 | 0.070 |
Why?
|
Incidence | 2 | 2024 | 21538 | 0.070 |
Why?
|
Pyrroles | 2 | 2010 | 1124 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2442 | 0.070 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 358 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2024 | 11878 | 0.070 |
Why?
|
Blood-Brain Barrier | 1 | 2012 | 1034 | 0.060 |
Why?
|
Neurophysiology | 1 | 2006 | 145 | 0.060 |
Why?
|
Sex Factors | 1 | 2020 | 10632 | 0.060 |
Why?
|
Glioblastoma | 1 | 2020 | 3464 | 0.060 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 1972 | 0.060 |
Why?
|
Cell Count | 1 | 2009 | 1832 | 0.060 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2010 | 591 | 0.060 |
Why?
|
Cell Survival | 2 | 2018 | 5777 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11095 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4648 | 0.060 |
Why?
|
Colony-Forming Units Assay | 2 | 2019 | 351 | 0.060 |
Why?
|
Fatal Outcome | 3 | 2021 | 1836 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2010 | 1194 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1627 | 0.060 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2474 | 0.060 |
Why?
|
Remission Induction | 1 | 2010 | 2410 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39348 | 0.060 |
Why?
|
Fibroblast Growth Factors | 1 | 2010 | 873 | 0.060 |
Why?
|
Thymus Gland | 1 | 2009 | 1266 | 0.060 |
Why?
|
Young Adult | 5 | 2024 | 60066 | 0.060 |
Why?
|
Viruses | 1 | 2008 | 373 | 0.060 |
Why?
|
Autoimmunity | 2 | 2024 | 1361 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6229 | 0.060 |
Why?
|
DNA Damage | 1 | 2013 | 2469 | 0.050 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2024 | 310 | 0.050 |
Why?
|
Vaccines, Attenuated | 1 | 2024 | 314 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2023 | 318 | 0.050 |
Why?
|
Age Factors | 1 | 2020 | 18412 | 0.050 |
Why?
|
Cell Lineage | 2 | 2024 | 2575 | 0.050 |
Why?
|
Enzyme Activation | 3 | 2015 | 3590 | 0.050 |
Why?
|
Immunosuppressive Agents | 3 | 2010 | 4206 | 0.050 |
Why?
|
Histocompatibility Testing | 1 | 2024 | 716 | 0.050 |
Why?
|
Lymphocyte Depletion | 1 | 2024 | 605 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1942 | 0.050 |
Why?
|
Transfection | 1 | 2010 | 5755 | 0.050 |
Why?
|
Receptors, Thrombopoietin | 1 | 2023 | 159 | 0.050 |
Why?
|
Ligands | 1 | 2009 | 3284 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2019 | 4937 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2024 | 6847 | 0.050 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2023 | 277 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8647 | 0.050 |
Why?
|
Apoptosis | 3 | 2015 | 9523 | 0.050 |
Why?
|
Lymphocytes | 1 | 2009 | 2614 | 0.050 |
Why?
|
Recombination, Genetic | 1 | 2006 | 1525 | 0.050 |
Why?
|
Adult | 8 | 2024 | 223646 | 0.050 |
Why?
|
Granulocytes | 1 | 2023 | 551 | 0.050 |
Why?
|
Hemolysis | 1 | 2023 | 417 | 0.050 |
Why?
|
Medical Oncology | 2 | 2024 | 2346 | 0.050 |
Why?
|
Critical Pathways | 1 | 2024 | 476 | 0.050 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 17140 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 422 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9755 | 0.050 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2022 | 165 | 0.050 |
Why?
|
Nervous System | 1 | 2004 | 544 | 0.040 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1596 | 0.040 |
Why?
|
Cytosine | 1 | 2021 | 213 | 0.040 |
Why?
|
Biomedical Research | 1 | 2016 | 3463 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6082 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13676 | 0.040 |
Why?
|
Daunorubicin | 1 | 2020 | 157 | 0.040 |
Why?
|
Cell Membrane | 1 | 2009 | 3655 | 0.040 |
Why?
|
Bone and Bones | 1 | 2010 | 2589 | 0.040 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2022 | 696 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 393 | 0.040 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 2 | 2010 | 32 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9118 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1385 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2024 | 863 | 0.040 |
Why?
|
Off-Label Use | 1 | 2020 | 185 | 0.040 |
Why?
|
HLA Antigens | 1 | 2024 | 1334 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3728 | 0.040 |
Why?
|
Down-Regulation | 2 | 2020 | 2937 | 0.040 |
Why?
|
Behavior, Animal | 1 | 2006 | 1862 | 0.040 |
Why?
|
Asparaginase | 1 | 2020 | 240 | 0.040 |
Why?
|
Erythroid Precursor Cells | 1 | 2019 | 211 | 0.040 |
Why?
|
Adrenal Insufficiency | 1 | 2020 | 195 | 0.040 |
Why?
|
Homeostasis | 1 | 2009 | 3348 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2022 | 583 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2019 | 267 | 0.040 |
Why?
|
Cytarabine | 1 | 2020 | 695 | 0.040 |
Why?
|
Antigens, CD | 2 | 2023 | 4035 | 0.040 |
Why?
|
Neurons | 3 | 2019 | 9514 | 0.040 |
Why?
|
Lysophosphatidylcholines | 1 | 2017 | 77 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 211 | 0.040 |
Why?
|
Vincristine | 1 | 2020 | 1040 | 0.040 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2009 | 2763 | 0.040 |
Why?
|
Antibiotic Prophylaxis | 1 | 2022 | 640 | 0.040 |
Why?
|
Pain | 2 | 2023 | 5100 | 0.040 |
Why?
|
Chromosome Aberrations | 1 | 2024 | 1778 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1014 | 0.030 |
Why?
|
Hemoglobins | 1 | 2023 | 1531 | 0.030 |
Why?
|
Milk Proteins | 1 | 2017 | 161 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1082 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 996 | 0.030 |
Why?
|
Graft Rejection | 1 | 2010 | 4492 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2009 | 4413 | 0.030 |
Why?
|
Graft Survival | 2 | 2019 | 3887 | 0.030 |
Why?
|
Registries | 2 | 2024 | 8375 | 0.030 |
Why?
|
Benzamides | 1 | 2022 | 1379 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 1606 | 0.030 |
Why?
|
Visual Pathways | 1 | 2020 | 557 | 0.030 |
Why?
|
Lymphoproliferative Disorders | 1 | 2019 | 528 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2019 | 806 | 0.030 |
Why?
|
Goals | 1 | 2021 | 717 | 0.030 |
Why?
|
Oligodendroglia | 1 | 2019 | 540 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2120 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1997 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2023 | 10474 | 0.030 |
Why?
|
Prednisone | 1 | 2020 | 1567 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1890 | 0.030 |
Why?
|
Immunization | 1 | 2019 | 1219 | 0.030 |
Why?
|
Recurrence | 2 | 2022 | 8509 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54926 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1197 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13671 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2023 | 9263 | 0.030 |
Why?
|
Motor Activity | 1 | 2004 | 2711 | 0.030 |
Why?
|
Peripheral Nervous System | 1 | 2015 | 151 | 0.030 |
Why?
|
Liver | 1 | 2009 | 7577 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2022 | 1613 | 0.030 |
Why?
|
Endocytosis | 1 | 2018 | 956 | 0.030 |
Why?
|
DNA-Binding Proteins | 1 | 2011 | 9615 | 0.030 |
Why?
|
Spectrophotometry | 1 | 2013 | 292 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2457 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5797 | 0.030 |
Why?
|
Reference Values | 1 | 2020 | 4938 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2018 | 2486 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 30010 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2017 | 1617 | 0.030 |
Why?
|
Colorimetry | 1 | 2013 | 151 | 0.030 |
Why?
|
Methotrexate | 1 | 2020 | 1721 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2062 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1561 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5315 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2885 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1679 | 0.030 |
Why?
|
Transcription Factors | 2 | 2023 | 12168 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6669 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 13421 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1367 | 0.020 |
Why?
|
Phagocytosis | 1 | 2017 | 1530 | 0.020 |
Why?
|
Astrocytes | 1 | 2019 | 1350 | 0.020 |
Why?
|
Drug Discovery | 1 | 2019 | 1068 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14783 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3428 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2932 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4620 | 0.020 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2010 | 34 | 0.020 |
Why?
|
Animal Structures | 1 | 2010 | 26 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2631 | 0.020 |
Why?
|
Cytoprotection | 1 | 2010 | 200 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 130 | 0.020 |
Why?
|
Rats | 2 | 2020 | 23760 | 0.020 |
Why?
|
Sulfotransferases | 1 | 2010 | 150 | 0.020 |
Why?
|
Lymphopoiesis | 1 | 2010 | 133 | 0.020 |
Why?
|
Myelopoiesis | 1 | 2010 | 135 | 0.020 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.020 |
Why?
|
Silver Nitrate | 1 | 2009 | 12 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2010 | 306 | 0.020 |
Why?
|
Middle East | 1 | 2009 | 233 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2019 | 12800 | 0.020 |
Why?
|
Health Status | 1 | 2022 | 4091 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 414 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2009 | 636 | 0.020 |
Why?
|
Nerve Net | 1 | 2020 | 2352 | 0.020 |
Why?
|
Drug Evaluation | 1 | 2009 | 642 | 0.020 |
Why?
|
Cattle | 1 | 2013 | 3819 | 0.020 |
Why?
|
Parents | 1 | 2022 | 3595 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12421 | 0.020 |
Why?
|
Exocytosis | 1 | 2009 | 323 | 0.020 |
Why?
|
Tissue Culture Techniques | 1 | 2009 | 290 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 615 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2330 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3623 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6793 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2540 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2015 | 895 | 0.020 |
Why?
|
COS Cells | 1 | 2009 | 1135 | 0.020 |
Why?
|
Receptor, Notch1 | 1 | 2010 | 519 | 0.020 |
Why?
|
Signal Transduction | 1 | 2010 | 23645 | 0.020 |
Why?
|
Axons | 1 | 2015 | 1677 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2019 | 3589 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 2998 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2019 | 7140 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2010 | 691 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5341 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2010 | 725 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2024 | 5367 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3629 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1968 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4503 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12840 | 0.020 |
Why?
|
Mice, SCID | 1 | 2010 | 2627 | 0.020 |
Why?
|
beta Catenin | 1 | 2010 | 1047 | 0.020 |
Why?
|
Nitriles | 1 | 2010 | 980 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9419 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2022 | 10266 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5804 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2004 | 775 | 0.010 |
Why?
|
Electroencephalography | 1 | 2019 | 6314 | 0.010 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2009 | 952 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9538 | 0.010 |
Why?
|
Luciferases | 1 | 2004 | 713 | 0.010 |
Why?
|
Adenoviridae | 1 | 2007 | 1092 | 0.010 |
Why?
|
Isoenzymes | 1 | 2007 | 1688 | 0.010 |
Why?
|
Cysteine | 1 | 2007 | 897 | 0.010 |
Why?
|
Muscles | 1 | 2007 | 1582 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2021 | 16045 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 26379 | 0.010 |
Why?
|
Protein Transport | 1 | 2007 | 1951 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22291 | 0.010 |
Why?
|
Plasmids | 1 | 2004 | 2269 | 0.010 |
Why?
|
Phosphorylation | 1 | 2010 | 8317 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2006 | 4120 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2004 | 2633 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4580 | 0.010 |
Why?
|
Stem Cells | 1 | 2010 | 3537 | 0.010 |
Why?
|
Blotting, Western | 1 | 2004 | 5027 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10101 | 0.010 |
Why?
|
Sepsis | 1 | 2010 | 2608 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5703 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17622 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11928 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7876 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7608 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 40218 | 0.000 |
Why?
|